查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
獸醫學中單克隆抗體的市場規模、佔有率和趨勢分析報告：按用途、動物物種、最終用戶、地區和細分市場預測，2023-2030
市場調查報告書
商品編碼
1321473

獸醫學中單克隆抗體的市場規模、佔有率和趨勢分析報告：按用途、動物物種、最終用戶、地區和細分市場預測，2023-2030

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫學中單克隆抗體市場成長和趨勢

Grand View Research, Inc.的最新報告顯示，到2030年，全球獸醫學單克隆抗體市場規模預計將達到24.2億美元，2023年至2030年年複合成長率為17.1%。

寵物數量的增加加上寵物支出的增加預計將推動市場成長。此外，犬特應性皮炎患病率的增加可能會推動預測期內的市場成長。

儘管受到 COVID-19 大流行的影響，獸醫保健行業從2019年到2020年仍實現了 8%的穩定成長。與其他市場相比，經濟衰退對動物保健行業的影響相對較小。疫情給動物醫院和獸醫的商業模式帶來了一些變化。傳統獸醫醫院預計將透過銷售生物製劑和藥品等高利潤產品獲得大部分收入。

癌症的增加，尤其是狗的癌症的增加，預計將為市場提供成長基礎。根據美國獸醫協會 (AVMA) 的資料，四分之一的狗預計會在生命中的某個階段出現腫瘤跡象。腫瘤是一種常見於狗的癌症。疼痛管理是治療犬腫瘤最重要的方面之一。這也可以用單克隆抗體來治療。

市場競爭非常激烈，有幾家主要參與者進入該市場。隨著市場中巨大機遇的出現，市場上的各個參與者都在投資以成為領先者。例如，2021年10月，Zoetis在愛爾蘭收購了一家新的開發和製造單位，以提高其獸醫學單克隆抗體（mAb）的產能。

預計這將加強其獸醫治療生物製藥的產品組合。此外，2021年8月，Elanco以約4.44億美元收購了Kindred Biosciences。這幫助Elanco進入皮膚科市場，補充了產品平臺，並增強了其在生物製劑和單克隆抗體方面的研發能力。

此外，2023年 5月，Elanco 宣布使用單克隆抗體對致命的犬細小病毒病進行突破性治療。這種單次靜脈注射可以治療病犬和幼犬中由細小病毒引起的症狀，無論是否接種疫苗。

獸醫學中的單克隆抗體市場報告亮點

  • 從動物類型來看，由於人們擴大採用狗作為寵物，以及針對狗疾病治療的研究和開發的增加，到2022年，狗細分市場將佔據壓倒性的收入佔有率。
  • 從用途來看，由於犬類特應性皮炎的患病率不斷增加，皮膚科領域在2022年佔據了最大的市場佔有率，超過 50%。
  • 由於獸醫醫院擁有先進的治療設施，到2022年，獸醫醫院細分市場將佔據最終用戶的主導市場佔有率。
  • 由於該地區存在主要市場參與者，2022年北美將佔據最大市場佔有率，約為 40%。

目錄

第1章 調查方法和範圍

  • 市場區隔和範圍
  • 調查方法
  • 資訊或資料分析
  • 常見調查方法
  • 調查範圍和先決條件
  • 市場形成和檢驗
  • 型號詳情
  • 二手資訊清單

第2章 執行摘要

第3章 市場變量、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/輔助市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 市場機會分析
    • 市場問題分析
  • 行業分析
    • 波特
    • PESTEL
  • 法律規範
  • 產品平臺分析
  • COVID-19 影響分析

第4章 獸醫學單克隆抗體市場：動物種類估算及趨勢分析

  • 細分儀表板
  • 獸醫單克隆抗體市場：按動物類型分類的變異分析，百萬美元，2022年和2030年
  • 狗
  • 其他

第5章 獸醫學單克隆抗體市場：用途預估及趨勢分析

  • 細分儀表板
  • 獸醫學單克隆抗體市場：用途變化分析，百萬美元，2022年和2030年
  • 皮膚科
  • 疼痛
  • 其他

第6章 獸醫學單克隆抗體市場：最終用戶估計和趨勢分析

  • 獸醫學單克隆抗體市場：最終用戶變異分析，百萬美元，2022年和2030年
  • 動物醫院
  • 其他

第7章 獸醫學單克隆抗體市場：區域估算及趨勢分析

  • 獸醫學單克隆抗體市場：2022年和2030年區域變化分析
  • 北美
    • SWOT分析
    • 2018年至2030年北美獸醫單克隆抗體市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2018-2030年歐洲獸醫學單克隆抗體市場估計和預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • SWOT分析
    • 2018-2030年亞太地區獸醫學單克隆抗體市場預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 2018-2030年拉丁美洲獸醫單克隆抗體市場估計和預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 2018-2030年中東和非洲獸醫單克隆抗體市場估計和預測
    • 南非
    • 沙烏地阿拉伯

第8章 競爭形勢

  • 市場參與分類
  • 主要公司簡介
    • Zoetis
    • Merck &Co, Inc.
    • Elanco
    • Boehringer Ingelheim GmbH
    • Indian Immunologicals Ltd
    • Virbac
  • List of Other Players（inclusive of companies with pipeline products）
Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights

  • Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. SWOT Analysis
    • 7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participation Categorization
  • 8.2. Key Company Profiles
    • 8.2.1 Zoetis
    • 8.2.2 Merck & Co, Inc.
    • 8.2.3 Elanco
    • 8.2.4 Boehringer Ingelheim GmbH
    • 8.2.5 Indian Immunologicals Ltd
    • 8.2.6 Virbac
      • 8.2.6.1. Participant's Overview
      • 8.2.6.2. Product Benchmarking
      • 8.2.6.3. Financial Performance
      • 8.2.6.4. Strategy Mapping
  • 8.3. List of Other Players (inclusive of companies with pipeline products)

List of Tables

  • Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
  • Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 73 Participant's overview
  • Table 74 Financial performance
  • Table 75 Product Benchmarking
  • Table 76 Key companies undergoing strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Ansoff's matrix analysis
  • Fig. 14 Heat map analysis
  • Fig. 15 Market penetration vs growth prospect mapping
  • Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
  • Fig. 17 Strategy mapping
  • Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
  • Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
  • Fig. 20 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
  • Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
  • Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 25 Pain market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
  • Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
  • Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: 2022
  • Fig. 32 Regional outlook, 2018 & 2030
  • Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participant categorization